Methylprednisolone EP Impurity D (Hyrdrous)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Methylprednisolone EP Impurity D (Hyrdrous)

● In Stock

Catalogue No.:VE000089
CAS No.:N/A
Mol. Formula:C22H28O4. H2O
Mol. Weight:374.47 g/mol

Additional information on Methylprednisolone EP Impurity D (Hyrdrous)

Parent drug

Methylprednisolone

IUPAC Name

(Z/E)-11β, 20-Dihydroxy-6α-methylpregna-1, 4, 17(20)-triene-3, 21-dione hydrate

Synonyms

N/A

Description

It is an impurity present in Methylprednisolone, Methylprednisolone is a prednisolone derivative glucocorticoid, which inhibits pro-inflammatory signals and promotes anti-inflammatory signals. corticosteroids decreased vasodilation and permeability of capillaries and also decreased leukocyte migration to sites of inflammation. Glucocorticoids inhibit neutrophil apoptosis and emargination they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives they inhibit NF-Kappa B and inflammatory transcription factors.

References

Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., … Kim, H. (2013). A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology, 9(1). https://doi.org/10.1186/1710-1492-9-30 ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url